Request a document copy: Efficacy of olaparib in advanced cancers with germline or somatic tumor mutations in BRCA1, BRCA2, CHEK2 and ATM: A Belgian precision tumor-agnostic phase II study

all files (of this document) in restricted access
the file(s) you requested
Cancel